Turkey Over-the-Counter (OTC) Healthcare Market Size by Categories, Distribution Channel, Market Share and Forecast, 2021-2026

The publisher's Country Profile report on the OTC healthcare sector in Turkey provides insights on high growth markets to target, trends in the usage of category level distribution data and companies market shares.

The Turkish OTC healthcare sector is led by the analgesics category in value terms in 2021. The vitamins and minerals category is forecast to register the fastest value growth during 2021-2026. Drug stores & pharmacies is the leading channel in the distribution of OTC healthcare in the country. Novartis, Nobel Ilac San ve Tic A.S., and Abdi Ibrahim Ilac Sanayi ve Ticaret are the top three companies in the Turkish OTC healthcare sector.

What else is contained?

• Sector data: Overall sector value data with growth analysis for 2016-2026
• Category coverage: Value and growth analysis for Analgesics, ‘cough and cold preparations’, first aid kits, indigestion preparations, medicated skin products, ‘plasters & bandages’, topical OTC medicines, traditional medicines, ‘vitamins and minerals’ and ‘other OTC healthcare products’ with inputs on individual segment share within each category and the change in their market share forecast for 2021-2026
• Leading players: Market share of companies (in value terms) and private labels (in value terms) in 2021
• Distribution data: Percentage of sales within each category through distribution channels such as cash & carries and warehouse clubs , convenience stores, drug stores & pharmacies, food & drinks specialists, hypermarkets & supermarkets, and other general retailers

Scope

• The per capita expenditure of OTC healthcare in Turkey was lower than both the global and regional levels in 2021
• The Turkish OTC healthcare sector is expected to register growth at a CAGR of 39% in terms of value during 2021-2026
• Drug stores & pharmacies was the leading distribution channel in the South Korea OTC healthcare sector, with a value share of 694% in 2021
• Novartis accounted for a value share of 20.9% in 2021

Reasons to Buy

• Identify high potential categories and explore further market opportunities based on detailed value and volume analysis
• Existing and new players can analyze key distribution channels to identify and evaluate trends and opportunities
• Gain an understanding of the total competitive landscape based on detailed company share analysis to plan effective market positioning
• Our team of analysts have placed a significant emphasis on changes expected in the market that will provide a clear picture of the opportunities that can be tapped over the next five years, resulting in revenue expansion
• The packaging analysis report helps manufacturers, in identifying the most commonly used packaging materials in the sector
• Analysis on key macro-economic indicators such as real GDP, nominal GDP, consumer price index, household consumption expenditure, population (by age group, gender, rural-urban split, and employed people and unemployment rate. It also includes economic summary of the country along with labor market and demographic trends